Latest News & Features
Americas
A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court. 17 April 2026
Careers
The Hong Kong partner brings more than 20 years’ experience and specialises in trademark strategy, cross-border enforcement, and brand protection across Asia and beyond. 17 April 2026
Careers
Fresh hire, who will take up his new role in May, brings years of expertise in pharmaceuticals and artificial intelligence to the firm’s Frankfurt practice. 16 April 2026
Americas
The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations. 16 April 2026
Big Pharma
The Danish pharma giant is turning to artificial intelligence as it faces patent expiry, falling shares and intensifying competition from Eli Lilly. 15 April 2026
Americas
A US district court has allowed key elements of the generic drugmaker’s case against a rival to move forward, while drawing clear limits on how far the complaint can reach. 14 April 2026
Europe
New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential funding left untapped, as structural barriers persist. 13 April 2026
Americas
The US tech company targets a disgruntled ex-employee for threatening to sell its trade secrets if he does not receive an “unreasonable fee”. 13 April 2026
Europe
Europe’s latest patent fee increases are modest at the EPO but include a rare steep hike in the UK, forcing applicants to reassess filing routes, portfolio value, and long-term cost strategies, say James Bell and Yelena Morozova. 13 April 2026
Americas
The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners. 10 April 2026